Quest Diagnostics Incorporated (DGX) vs IDEXX Laboratories, Inc. (IDXX)

Quest Diagnostics Incorporated and IDEXX Laboratories, Inc. are both Diagnostics & Research companies. IDEXX Laboratories, Inc. is the larger, with a market value of $43.1B against $26.4B — 1.6× the size. Quest Diagnostics Incorporated trades at the lower P/E: 24.6× against 39.1×. IDEXX Laboratories, Inc. grew revenue faster over the last twelve months: 12.8% against 9.87%. IDEXX Laboratories, Inc. has the higher net margin (25.0% vs 9.15%) and the higher return on invested capital (48.9% vs 7.94%). Across the 22 metrics below, IDEXX Laboratories, Inc. leads on 13 and Quest Diagnostics Incorporated on 9.

Valuation

Metric DGX IDXX Diagnostics & Research median
P/E 24.63 39.10 35.56
P/S 2.26 9.72 4.37
P/B 3.34 27.44 3.06
Price to free cash flow 19.34 35.76 35.76
EV/EBITDA 14.07 27.59 24.35
EV/Sales 2.69 9.77 5.51
Earnings yield 4.06% 2.56% (1.89%)
Free cash flow yield 5.17% 2.80% (0.15%)

Profitability

Metric DGX IDXX Diagnostics & Research median
Gross margin 33.11% 62.45% 50.89%
Operating margin 14.10% 32.03% (8.57%)
Net margin 9.15% 25.03% (6.37%)
Free cash flow margin 11.67% 27.17% 0.00%
Return on equity 14.03% 74.21% (2.92%)
Return on assets 6.43% 33.65% (6.71%)
Return on invested capital 7.94% 48.87% 0.00%

Growth

Metric DGX IDXX Diagnostics & Research median
Revenue growth (TTM) 9.87% 12.77% 7.69%
EPS growth (last fiscal year) 13.78% 22.59% 25.92%
Revenue growth, 5-year CAGR 3.18% 9.72% 7.40%
Net income growth, 5-year CAGR (7.06%) 12.74% 0.00%

Health

Metric DGX IDXX Diagnostics & Research median
Debt to equity 0.72 0.28 0.11
Current ratio 1.59 1.17 2.02
Net debt to EBITDA 2.47 0.18 0.70

Dividend

Metric DGX IDXX Diagnostics & Research median
Dividend yield 1.44% — 0.66%
Payout ratio 0.36 — 0.20

Size

Metric DGX IDXX Diagnostics & Research median
Market cap 26.40b 43.11b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack